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failure non cachexia group (421.80þ9.14 ng/ml) (P <0.05), (5) the
expression of p85, p-Akt and NF-kB: in cardiac cachexia group was
lower than in the heart failure non cachexia group (P <0.05) and
control group (P <0.05), but the heart failure non cachexia group was
higher than the control group (P <0.05); (6) the expression of caspase9
mRNA: in cardiac cachexia group(1.38þ0.03) was higher than in the
heart failure non cachexia group(0.49þ0.04) and control
group(0.62þ0.07) (P<0.05), (7) the expression of Bcl-xl mRNA: in
cardiac cachexia group (1.39þ0.20) was lower than in the heart failure
non cachexia group(8.03þ0.28) and control group(7.80þ0.15)
(P<0.05).
CONCLUSIONS (1) There were insulin and GH resistance in the heart
failure cachexia patients, (2) PI3K/Akt signal transduction pathways
was activated by phosphorylation in heart failure, which is play a
protective effect on the heart when combined with cachexia. and the
expression of p85, p-Akt and NF-kB were decreased, illustrate that
PI3K/Akt signal pathway was restrained, which eventually lead to cell
apoptosis. (3) PI3K/Akt signal transduction pathway may be a new
therapeutic target in cardiac cachexia.
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Effect of Eplerenone on Plasma TGF-b1 level in Patients with Chronic Heart
Failure
Yi Gu,1 Xinzheng Lu2
1Jiangbei People’s Hospital, Southeast University; 2First Afﬁliated
Hospital, Nanjing Medical University
OBJECTIVES Renin - angiotensin - aldosterone system (RAAS), by
affecting the nervous hormone levels, involves in the development of
chronic heart failure(CHF). Of interest, for patients with moderate to
severe chronic heart failure, on top of angiotensin-converting enzyme
inhibitors (ACEI) and beta blockers, eplerenone administration will
further reduce the total mortality. However, the therapeutic mecha-
nism for CHF with eplerenone administration is not yet fully
understood.
METHODS Renin - angiotensin - aldosterone system (RAAS), by affecting
the nervous hormone levels, involves in the development of chronic
heart failure(CHF). Of interest, for patients with moderate to severe
chronic heart failure, on top of angiotensin-converting enzyme inhibitors
(ACEI) and beta blockers, eplerenone administration will further reduce
the total mortality. However, the therapeutic mechanism for CHF with
eplerenone administration is not yet fully understood.
RESULTS Compared with conventional treatment, LVEF and 6-min-
ute walk test(6-MWT) distances increased, while LVP, LVEDD, IVS,
TGF-b1 level, BNP level and the blood pressure all reduced in patients
received eplerenone administration (P<0.05), TGF-b1 levels were
inversely correlated with LVEF, and positively correlated with BNP
level (P<0.05).
CONCLUSIONS Eplerenone can reduce plasma TGF-b1 level by
reversing cardiac remodeling and improve cardiac function in chronic
heart failure patients.
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Silencing microRNA-155 reduces LPS-induced cardiac apoptosis via
targeting pea15a
Hui Wang,1,1 Xiangqing Kong1,1
1The First Afﬁliated Hospital of Nanjing Medical University
OBJECTIVES Sepsis-related cardiac dysfunction is characterized by
inﬂammation and metabolic repression. microRNAs, a small non-
coding RNA, inhibit mRNA translation or promote mRNA degradation
through pairing to the 3’-UTR of target genes mRNA. MiR155 is up-
regulation as a continual feature of the mammalian inﬂammatory
response. In this study, we tested the hypothesis that miR155 regu-
lates in heart dysfunction with sepsis.
METHODS E.coli lipopolysaccharide (LPS)(5mg/kg) was administered
to C57BL/6 mice to induce a sepsis-induced cardiac dysfunction model
within 5-7 h. Cardiac function was assessed by Echocardiography
5w6h post–LPS administration. Myocardium were obtain within 7w9h
after LPS treatment for gene expression and protein analysis. A
systematic analysis of cardiac miRNA proﬁles using an established
miRNAarray was performed to assess dys-regulated miRNAs in sepsis-
induced cardiac dysfunction. To forced expression of miR155, miR155
agomirs were injected in the tail vein of C57B1/6J mice on 3 consec-
utive days with a total of 30 mg/kg agomir and inhibition of miR155 in
vivo by 80 mg/kg 155 antagomir followed by LPS administration.RESULTS LPS induced reduction 15% in Fractional shortening (%FS)
and 25% in ejection fraction (%EF). Expression of miR155 was
increased by 2 fold. Over-expressing of miR155 with systemic delivery
of agomir led to 5% decrease in FS and 10% in EF as compared to
scramble control. Aggravation of the LPS induced cardiac dysfunction
by miR155 agomir is not associated with alteration in inﬂammation or
cardiac metabolism. MiR155 agomir increased LPS- induced myocar-
dium apoptosis and increased ratio of Bax/Bcl-2 at the protein level.
Deﬁciency of miR155 markedly rescued the LPS induced heart failure
and apoptosis. In vivo, western bloting found that over-expression of
miR155 led to signiﬁcantly inhibition of Pea15a in mice. Using bioin-
formatics analyses and validated luciferase reporter assays, Pea15a
was identiﬁed as a novel miR155-target. Finally, we observed that
critically ill patients with sepsis had increased levels of miR155
compare with healthy control as well.
CONCLUSIONS The present study demonstrated that miR155 regu-
lates sepsis-related cardiac apoptosis by target gene Pea15a. Finally,
our results identify inhibition of miR-34a as a potential therapeutic
strategy to improve sepsis -induced heart failure.GW26-e4801
The correlations between iron metabolism and myocardial energy
expenditure in patients with chronic heart failure
Feng Lin, Qiong Zhan, Jinghai Hua, Dingji Zhu, Qingchun Zeng,
Dingli Xu
Department of Cardiology, Nanfang Hospital, Southern Medical
University
OBJECTIVES Chronic heart failure (CHF) is a major public health
burden worldwide and is associated with high morbidity, mortality
and cost. Recent study demonstrated that iron metabolism and
myocardial energy expenditure (MEE) were altered in CHF patients. In
this study, we aimed to analyze the effects, clinical signiﬁcance,
and possible correlations of iron metabolism on MEE in patients with
CHF.
METHODS We recruited 96 CHF patients [age: 67.411.5 years, males:
61.5%, New York Heart Association (NYHA) class (II/III/IV): 45/36/15] from
the Cardiology Department in Nanfang Hospital, Southern Medical Uni-
versity from January 2014 to January 2015. The concentrations of serum
hemoglobin, Fe, total iron-binding capacity, transferrin saturation,
transferrin, soluble transferrin receptor, ferritin, and Pro-BNP were eval-
uated. Echocardiography was used to assess LA, LV, PWTs, LVIDs, LVIDd,
LVEF, LVFS, andMEE. Iron deﬁciency was deﬁned as ferritin <100 ng/mL
or 100-300 ng/mL with transferrin saturation <20%.
RESULTS The patients were divided into iron-deﬁcient and iron-
sufﬁcient groups; the incidence of iron deﬁciency in all subjects was
38.5%. The differences of demographic characteristics (age, sex and
BMI) and HGB concentrations in two groups were similar (P＞0.05).
Interestingly, MEE was signiﬁcantly higher in the iron-deﬁcient group
[64.963 (51.555 to 78.300) cal/min vs. 40.176 (25.346 to 56.914) cal/
min, P＜0.001]. Similarly, MEE in patients with NYHA classes II and III
was signiﬁcantly higher in the iron-deﬁcient group (55.611.4 cal/min
vs. 39.717.5 cal/min, P¼0.002; 63.616.9 cal/min vs. 42.621.0 cal/
min, P¼0.003). Bivariate analysis conﬁrmed that MEE was signiﬁ-
cantly correlated with ferritin (r¼-0.406, P＜0.001), transferrin satu-
ration (r¼-0.307, P¼0.002), Pro-BNP (r¼0.333, P¼0.001), NYHA class
(r¼0.455, P＜0.001), LVEF (r¼-0.477, P＜0.001), LVFS (r¼-0.657, P＜
0.001), LV (r¼0.770, P＜0.001), and LVIDd (r¼0.748, P＜0.001). Mul-
tiple linear regression analysis on the above variables showed that
iron deﬁciency, higher LVIDd, NYHA class, and lower LVFS predicted
higher MEE (r2¼0.748, P＜0.001).
CONCLUSIONS Iron deﬁciency may play an important role in the
disorders of MEE in CHF patients, regardless of baseline HGB con-
centrations.CONGENITAL HEART DISEASE AND INTERVENTIONS
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Prediction of Spontaneous closure in isolated ventricular septal defects by
fetal echocardiography
Xing Li, Lingmei Qian
The ﬁrst afﬁliated hospital of Nanjing Medical University
OBJECTIVES By conducting a follow-up survey in children who
were diagnosed with simple ventricular septal defect(VSD) in their
mothers’ second trimester through fetal echocardiography, we hope
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Province, and to identify factors contributing to spontaneous closure
(SC) of VSD. We hope to provide a reference for prenatal counseling
and clinical decision making.
METHODS A total of 445 fetal patients who had been diagnosed with
isolated VSD by fetal echocardiographic in their mother’s second
trimester were enrolled in this retrospective study at Nanjing Mater-
nity and Child Health Care Hospital and Jiangsu Province Maternity
and Child Health Care Hospital between January 2011 and December
2013. Data in ultrasound record contained gestational weeks, mother’s
age, fetal heart rate, width of aorta and pulmonary artery, location
and diameter of the defect, direction of the shunt. Questions in the
interview contained: whether the defect was closed, speciﬁc time of
the SC, current treatment, gender, birth weight, whether premature
birth existed, whether there were infection or metabolic disease
during pregnancy, with or without a family history of heart disease.
RESULTS Effective follow-up was 257 cases, 44 cases received
termination of pregnancy, 213 infants were born. 8 cases died after
birth.205 cases survived, among which 19 cases underwent clinical
surgery, 24 cases were still not closed, SC occurred in 110 children
(49 closed during pregnancy, and 61 closed postpartum). The
post-natal death, children underwent surgery and children with
unclosed defects were classiﬁed as group 1, along with defects closed
postpartum and during pregnancy were classiﬁed as group 2 and
3 respectively. The comparison of echocardiography results
showed signiﬁcant differences (P <0.05) in the following data: defect
diameter (3.4220.972, 2.4260.599, 2.2920.479mm), birth weight
(3.0950.774,3.1740.535,3.4990.532kg), defect location, direction
of blood ﬂow through the defect. When SC used as a state variable and
the defect diameter as test variables, we get a receiver operating
characteristic curve : area under the curve is 0.842, Cut-off value is
2.55mm. Binary logistic regression analysis showed that birth weight
is a protective factor, while defect diameter is a risk factor for SC. The
probability of SC was described by the equation: probability ¼ (1 þ exp
[-2.125-.176*birth weightþ1.393*diameter])-1. We examine children
with VSD from January to March in 2014 according to the probability
formula, 19 out of 23 children were in line with forecasts.
CONCLUSIONS A. by using statistical analysis, cut-off value of the defect
diameter were 2.55mm in predicting the rate of SC in children with VSD
who were diagnosed in their mothers’ second trimester, the smaller the
defect was, the more likely SC will happen. B. greater birth weight, male
fetuses, muscle defect, full-term infants has higher probability of SC;
C. defect without bloodstream detection were easier to close.
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Comparative Study of Echo and Cardiovascular Cast in Fetus with CoA
or IAA
Liu Hong, Mingxing Xie
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Laboratory of Molecul
OBJECTIVES The coarctation or interruption of aortic arch is a rare kind
of congenital malformation of great vascular, always combined with
multiple cardiac malformation. The echocardiology can display the
abnormal structure of the inner hear cavity, excluding the great vascular
lesion, especially the isthmus and the conjunction of descending aorta
and PDA. Our research is to assess the sonographical features of fetal CoA
or IAA with the comparative study of echo and cardiovascular cast.
METHODS All the 3 cases of CoA or IAA diagnosed by fetal echo-
cardiology were made into cardiovascular cast. First we peel the
umbilical vein from the abdominal wall, injected the mixture of
heparin and perfusate slowly with low tension, then we got the car-
diovascular cast. The models display the space conﬁguration of heart
cavity and the location relationship of great vessels. These datas
compared with the sonographical features, we can get the point of
abnormalities according to the cardiovascular cast.
RESULTS The 3 cases of fetal CoA or IAA all conﬁrmed by fetal
echocardiology and heart sample cast. Two cases were CoA, the
characteristic ﬁndings include:
(1) the coarctation of the ascending aorta and arch, with narrow diam-
eter (0.14cm) and reverse ﬂow;
(2) aortic valve and mitral valve stenosis, two ventricular outlet
conﬁrmed by the cardiovascular cast, which showed the aorta on the
anteriorly left with the pulmonary artery on the posteriorly right,
combined with HLHS;
(3) the left and right PA crossover each other up and down.The another case was IAA, the characteristic ﬁndings include:
(1) the echocardiology showed severe constriction(0.17cm) or interrup-
tion of aortic arch, the cavity and ﬂow of descending aorta was not
evident, the cast demonstrated the IAA with type A, interrupted
between the PDA and left sub clavicular artery;
(2) large VSD (Taussing-Bing), pulmonary artery dilated;
(3) also with the crossover PA.
CONCLUSIONS Fetal echocardiology as the only observation way to
the congenital heart disease, is still uncertain with the diagnosis to the
morphological and location features of the great vessels. The combi-
nation of cardiovascular cast and fetal echocardiology would improve
the speciﬁcity and veracity of fetal CHD diagnosis.
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Flow ﬁeld changes of right ventricle in diastole pre- and post-operation in
patients with atrial septal defect by vector ﬂow mapping
Jinfeng Liu, Yali Yang
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OBJECTIVES In this study, we apply a novel echocardiographic method,
vector ﬂow mapping (VFM), to assess the ﬂow ﬁeld changes of the right
ventricle in diastole pre- and post-operation in patients with ASD, inves-
tigating its value in the evaluation of hemodynamic changes ASD patients.
METHODS 20 patients with secundum ASD were enrolled as patient
group, while 20 healthy volunteers were chosen as controls group.
The characteristics of ﬂow ﬁeld pre- and post-operation were
analyzed by vector, streamline and vortex modes, separately. The
parameters including diastolic peak velocity(Vp), diastolic peak
ﬂow(Fp) and diastolic Qþ(DQþ) at basal, mid and apical segments of
the two groups were also recorded and compared with VFM.
RESULTS Compared with normal group, the ASD group had intensive
but disordered vector and stream lines and vortexes with more area
below the tricuspid leaﬂets in diastolic right ventricle before opera-
tion. After operation, the line intensity and direction consistence were
recovered and the vortexes were reduced to some degree, but still
different from the normal group. The Vp, Fp and DQþ in each segment
of right ventricle after operation were also lower than those before
ASD closure, but higher than control group ( P<0. 05).
CONCLUSIONS The ﬂow ﬁeld hemodynamics of the right ventricle in
ASD patients was recovered after operation, but still not back to
normal in the short time. The vector ﬂow mapping could be used in
the postoperative hemodynamic monitoring and follow-up.
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Analysis research of fetal echocardiography in the diagnosis of fetal
coarctation and its ultrasonic hemodynamics
Zhuo Chen, Yihua He
Beijing Anzhen Hospital, echocardiography department
OBJECTIVES Analyze the fetal echocardiography in the diagnosis of fetal
coarctation and its ultrasonic hemodynamics and to explore the clinical
application of fetal echocardiography in the diagnosis of coarctation.
METHODS From August 2010 to December 2014, 114 fetus diagnosed
as coarctation were selected from the 11647 cases of fetus, gestational
aged 20 to 38 weeks, with pathologic results or postnatal follow-up
results as the gold standard, different fetal echocardiography pa-
rameters including the ratio of left and right ventricular diameter (LV/
RV), the ratio of pulmonary artery and the aorta (PA/AO), the aortic
isthmus, the aortic inner diameter ratio (AI/AO and AI/DA), and the
velocity ratio (PAv/AOv, ARvs/DAvs, ARvd/DAvd, MCAvs/inUAvs, MCAvd/
inUAvd, MCARI/inUARI, MCAPI/inUAPI, MCAvs/exUAvs, MCAvd/exUAvd,
MCARI/exUARI, MCAPI/exUAPI), were selected to evaluate the diag-
nostic value of each above index in the diagnosis of coarctation.
RESULTS 144 cases of fetus were included in this study, in which 53
cases were successful followed-up, including 22 cases with coarcta-
tion and 31 cases without coarctation. The ROC curve of different in-
dexes were drawn and the results showed that the AUC of the inner
diameter ratio (LV/RV, PA/AO, AI/DA, MCAvd/inUAvd, MCARI/inUARI,
MCAPI/inUAPI) were>0.5, which had certain diagnostic accuracy (P <
0.05). The consistency of any single ratio was relatively low, when the
number of the ratio increased to 3, the Kappa value was 0.687 (P ¼
0.000); and increased to 4, the Kappa value was 0.649 (P ¼ 0.000). If
any six indexes were taken as criteria, any positive index was taken as
